학술논문
Efficacy and safety of high-dose lanreotide autogel in patients with progressive pancreatic or midgut neuroendocrine tumours: CLARINET FORTE phase 2 study results
Document Type
Article
Author
Source
In European Journal of Cancer November 2021 157:403-414
Subject
Language
ISSN
0959-8049